Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018.

Tessa du ToitTonya M EsterhuizenNicki TiffinAhmed A AbulfathiHelmuth ReuterEric H Decloedt

Published in: BMC infectious diseases (2020)

Patients exposed to both TNF-α and non-TNF-α biologic therapies may have a higher incidence of tuberculosis disease compared to the background risk of 681 cases per 100,000 per year in the Western Cape.

Keyphrases

south africa
rheumatoid arthritis
hiv positive
end stage renal disease
mycobacterium tuberculosis
ejection fraction
newly diagnosed
chronic kidney disease
cardiovascular disease
pulmonary tuberculosis
hiv aids
peritoneal dialysis
type diabetes
emergency department
drug induced